SBRA Earnings

SBRA reported its FY2025Q4 earnings on 2026-02-23, showcasing a revenue of against an estimate of 195.79M, resulting in a 0% surprise. The EPS was 0, surpassing the expected 0.38 by 0%. The stock experienced a 0% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following SBRA's FY2025Q4 earnings announcement on 2026-02-23, the stock price moved by 0% on the day of the release. Over the subsequent five days, it saw a 0% change. Historically, SBRA's stock price tends to shift by an average of -2.26% in the 10 days leading up to earnings and -0.09% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate SBRA's annual revenue to reach 204.07M, while the EPS is projected at 0.18. These estimates reflect recent revisions, with revenue estimates revised upward by 1.32% and EPS estimates revised upward by 4.95% over the past three months, indicating analyst expectation in the company's performance.

The correlation between SBRA's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were revised upward by 1.32%, while EPS estimates moved revised upward by 4.95%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, SBRA's stock price typically moves by -2.26% in the 10 days before its earnings and -0.09% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of 0.18 and revenue of 204.07M.

The earnings call reveals strong financial health, strategic growth in the SHOP portfolio, and favorable market conditions for senior housing. Despite minimal skilled nursing investments, the company is focusing on high-growth areas with robust occupancy potential. Shareholder returns are stable with no debt concerns, and the market strategy is well-received. The Q&A did not reveal significant risks, and management's optimistic guidance supports a positive outlook. Given the market cap of $3.5 billion, the stock is likely to experience a positive movement of 2% to 8% over the next two weeks.